Prev   Next       Pause   Play    




Listen to webcasts from the comfort of home on important issues concerning gynecologic cancers discussed by leading national experts and have a chance to ask your questions.  Upcoming webinars are listed below. 

From the Ovarian Cancer National Alliance…..
Ovarian Cancer and Oral Contraceptives

Log on to a free online chat sponsored by the Ovarian Cancer National Allianceon March 18 at 3:00 pm EST with legal and medical experts about ovarian cancer, oral contraceptives and how they intersect with a case that the Supreme Court will hear in March.  For more details, go to:


From the Ovarian Cancer Research Fund…..
Understanding Clinical Trials

On Wednesday, March 19th at 6:00 p.m EST, the Ovarian Cancer Research Fund (OCRF) will host "Understanding Clinical Trials."  Rachel Grisham, MD of Memorial Sloan Kettering Cancer Center will address what clinical trials are, why they are important, and how they work, as well as pros and cons of enrolling in trials, things to think about, and questions to ask your doctor about clinical trials. Register at: The archived webinar will be available following the original presentation.

Additional topics for OCRF’s webinar series in 2014 include:

  • April: Chemotherapy: What to Expect
    June: Research Update from 2014 Medical Meetings
  • September: Breast and Ovarian Cancer
  • October: Nutrition for Ovarian Cancer Survivors
  • November: Precision Therapeutics for Ovarian Cancer

Support for the OCRF webinar series has been provided by Genentech. To view all past presentations, visit OCRF at: webinar archive

A Radioshow for Cancer Patients

Listen to "Frankly Speaking About Cancer" every Tuesday at 4pm eastern time (1pm pacific time). The host is Kim Thiboldeaux, President and CEO of the Cancer Support Community, stives to empower her listeners to live well with cancer. Click here to visit the website. You can also find past episodes available for listening!



We thank our generous sponsors of the 2013 Survivors Tea!

Platinum Sponsors:

Mid Atlantic Gynecologic Oncology and Pelvic Surgery Associates

Silver Sponsors:

Clare and Kevin Donelan
Pat Goldman
Joan Stieber
Fran and Warren Stolusky
JoAnn and Howard Symons
Seggerman Homes, LLC
Paige Whitaker

In-Kind Sponsors:

Amrita Singh
Bigelow Tea
Kleen Kanteen
La Fresh
Mighty Leaf Tea
The Republic of Tea
Teal Toes

Is Your Body Talking? Take Time to Listen

Ovarian and Endometrial Cancer Survivor Stories

DC Department of Health, DC Cancer Consortium, and OGCC/Rhonda's Club partnered to conduct an interpersonal study of women who have survived ovarian and endometrial cancers.



The Future of Ovarian & Gynecologic Cancer, presented by Dr. Michael V. Seiden, MD, PhD, President and CEO of Fox Chase Cancer Center, Philadelphia, PA, to Rhonda's Club on September 12, 2011.

Click on the image above to watch the video.

Click here to download slides accompanying Dr. Michael V. Seiden's presentation.

view our calendar of events >



New Study Confirms Importance of Treatment by Gynecologic Oncologists

New research presented at the annual meeting of the Society of Gynecologic Oncologists in early March confirmed the critical importance of seeking treatment for ovarian cancer from a gynecologic oncologist.  The study, led by Dr. Robert E. Bristow, found most women with ovarian cancer receive less than optimal care because they see doctors who do not specialize in treating ovarian cancer. The five-year survival rate and disease-free intervals of patients treated by gynecologic oncologists far surpass those of patients whose surgeons were not gynecologic oncologists.  To read more about this new research,  CLICK HERE

New Hope for Early Detection of Ovarian and Endometrial Cancers

Cara Tenenbaum, Vice President for Policy and External Affairs at OCNA and a Rhonda's Club board member, reports that a small study of 46 women showed that examining cells on the cervix with the Pap test can help identify ovarian and uterine cancers. In this study, DNA analysis detected 41% of ovarian cancer cases.  For more information, read the article on or

Cervical Cancer Screening

The U.S. Preventive Services Task Force announced on March 14, 2012 its final recommendation on screening for cervical cancer. For more information, CLICK HERE.

Ovarian Cancer Advocates Troubled by FDA Decision on Avastin and Breast Cancer

Posted by the Ovarian Cancer National Alliance (OCNA)

On November 18, 2011 the Food and Drug Administration (FDA) announced that it would remove metastatic breast cancer from the label for Avastin (bevacizumab). This decision follows recommendations made in June by the FDA Oncologic Drugs Advisory Committee. Responding to today’s decision, OCNA CEO Karen Orloff Kaplan, MSW, MPH, ScD, expressed concern that the removal of metastatic breast cancer from the Avastin label could negatively affect women with ovarian cancer, for whom the drug is used off-label.  read more >>

Ovarian Cancer Patients with BRCA Mutations May Fare Better than Non-Carriers

A large, multicenter study shows that women with ovarian cancer who have mutations in the BRCA1 or BRCA2 genes have better survival rates than women who do not have such mutations. The study is also the first to provide strong evidence that ovarian cancer prognosis is better for women with BRCA2 mutations than women with BRCA1 mutations. The results were published online today in JAMA. Inherited mutations in BRCA1 and BRCA2 are the strongest known genetic risk factors for breast cancer and epithelial ovarian cancer, the most common form of ovarian cancer. To read more click here.

more resources >